Description: HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and distributes pharmaceutical products in North American markets. It is focused on treatment products for the central nervous system and cardiovascular specialties. The company is headquartered in Toronto, Canada.
Home Page: www.hlstherapeutics.com
10 Carlson Court
Etobicoke,
ON
M9W 6L2
Canada
Phone:
647 495 9000
Officers
| Name | Title |
|---|---|
| Mr. Craig Stuart Millian M.B.A. | CEO & Director |
| Mr. John Hanna CPA, CGA, M.B.A. | CFO & Non-Independent Director |
| Dr. Jason A. Gross Pharm.D. | Vice President of Scientific Affairs |
| Mr. Ryan C. Lennox B.A., J.D. | Senior VP of Legal, HR & Compliance and Corporate Secretary |
| Mr. Brian T. Walsh | Chief Commercial Officer |
| Dave Mason | Investor Relations Officer |
| Mr. David Spence | VP & Corporate Controller |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 169.4915 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.9619 |
| Price-to-Sales TTM: | 1.3786 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 91 |